|
Public
Hearing on Direct-to-Consumer Promotion of Medical Products
November 1 and 2, 2005
Presentations
Panel 1
- Brief Summary Research: Improving Patient Comprehension [PPT]
Sharon D. Allison-Ottey, COSHAR Inc.
- Comprehension of Benefits vs. Risks: Fair balance in DTC? [PDF]
Ruth Day, Duke University
- Re-evaluating risk messages in TV drug commercials [PPT],
Lewis Glinert, Ph.D., Dartmouth College
The Effect of Direct to Consumer Television Advertising on the
Timing of Treatment [PPT],
Andrew N. Kleit, The Pennsylvania State University,
Panel 2
- Advancing Public Health Through Effective Consumer Health
Communication [PPT], Pat Kelly, Pfizer
- Celebrities in Advertising: What Are They Likely or Not Likely
To Do? [PDF], Abhilasha (Abby) Mehta,
Ph.D., Gallup & Robinson, Inc.
- Direct-to-Consumer Advertising of COX-2 Inhibitors: Effect on
Appropriateness of Treatment [PPT],
Michele Spence, Kaiser Permanente
- Recent Sufferers: Exploring Patient Behavior From Discovery to
Diagnosis [PPT], Christine Winnicki
Panel 3
- Public Hearing on Direct-to-Consumer Promotion of Medical
Products [PPT], James Gardner, One to
One Interactive
- Public Hearing on Direct-to-Consumer Promotion of Medical
Products [PPT], Gail H. Javitt, JD, MPH,
Johns Hopkins University
- Consumer Directed Promotion of Regulated Medical Products [PPT],
Bill Person, 50PlusWebHealth
- FDA Public Hearing on Consumer-Directed Promotion of Regulated
Medical Products AdvaMed Presentation [PPT],
Marlene K. Tandy, M.D., J.D., Johnson & Johnson
Panel 4
- Direct-to-Consumer Promotion of Regulated Medical Products [PPT],
Gary C. Stein, Ph.D., American Society of Health-System
Pharmacists
- Direct-to-Consumer Promotion of Medical Products [PPT],
Diana Zuckerman, Ph.D., National Research Center for Women &
Families
Panel 5
- Statement before the Food and Drug Administration Public
Hearing on Direct-to-Consumer Advertising [PPT],
Judith A. Cahill, Academy of Managed Care Pharmacy
- Direct-to-consumer advertising of prescription medicines in
the United States and New Zealand: An analysis of regulatory
approaches and consumer responses [PPT],
John E. Calfee, American Enterprise Institute
- Food and Drug Administration Hearings on Direct to Consumer
Advertising [PPT], James H. Davidson,
Davidson & Company
Panel 6
- DTCA: The Need for Greater Regulation and Enforcement [PPT],
Alex Sugarman-Brozan, Prescription Access Litigation
- DTC Advertising Hearing [PPT], Kim
Witczak
- FDA Public Hearing on Direct-to-Consumer Promotion of Medical
Products [PPT], Meg
Columbia-Walsh, Managing Director, Faith Popcorn’s BrainReserve
- Gary Ruskin Testimony, Executive Directory, Commercial Alert [PDF]
Panel 7
- FDA Public Hearing on Direct-to-Consumer Promotion of Medical
Products [PPT], Meg
Columbia-Walsh, Managing Director, Faith Popcorn’s BrainReserve
PDF requires the free Adobe
Acrobat Reader
Back
to Top
DTC Meeting Info
Date created: November 9, 2005, updated February 9, 2006 |
|